Document is current
Any future updates will be listed below
-
Authors
Levitan, Emily B.
Van Dyke, Melissa K.
Chen, Ligong
Durant, Raegan W.
Brown, Todd M.
Rhodes, J. David
Olubowale, Olusola
Adegbala, Oluwole Muyiwa
Kilgore, Meredith L.
Blackburn, Justin
Albright, Karen C.
Safford, Monika M.
-
Funding
Funding for this research was provided by:
U.S. Department of Health and Human Services (U01 NS041588)
Amgen
National Heart, Lung, and Blood Institute (R01 HL080477, K24 HL111154)
- License Information
-
More Information
Article History
Received: 2 March 2017
Accepted: 11 September 2017
First Online: 16 September 2017
Ethics approval and consent to participate
: This research was conducted in accordance with the Declaration of Helsinki. The REGARDS study was approved by the Institutional Review Boards of the University of Alabama at Birmingham, the University of Vermont, Wake Forest University, and the University of Cincinnati. Participants provided written informed consent and completed medical record release forms authorizing study investigators to retrieve medical records for research purposes. The Institutional Review Board of the University of Alabama at Birmingham approved the current research.
: Not applicable.
: This research was supported by an academic collaboration between University of Alabama at Birmingham and Amgen, Inc. EBL reports serving on advisory boards for Amgen Inc. and consulting for Novartis. MKV was an employee of Amgen, Inc., at the time the work was conducted.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
